Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 4/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.37 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.37 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.37 |
| ▸ | CDC25B | P30305 | 4/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.36 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3490324 | 0.88 | CA12 (0.50) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL18942038 | 0.87 | CA12 (0.51) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL13498635 | 0.86 | TACR2 (0.41) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL5688905 | 0.84 | TACR2 (0.38) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL3489164 | 0.84 | TACR2 (0.38) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL20820953 | 0.84 | KMT2A (0.46) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL6552379 | 0.83 | PTPN1 (0.50) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL8340914 | 0.82 | TACR2 (0.37) | TACR2CA12CA1CA2CA4 | |
| SCHEMBL7995830 | 0.82 | CA12 (0.53) | CA12CA1CA2CA4CA5A | |
| SCHEMBL8507736 | 0.82 | CA12 (0.53) | CA12CA1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190055276-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY | 2019-02-21 | — | — | US | disclosed |
| US-10059736-B2 | Ionic liquid supported synthesis | MCGILL UNIVERSITY (CA) | 2018-08-28 | — | — | US | disclosed |
| US-20100041869-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY (CA) | 2010-02-18 | — | — | US | disclosed |
| EP-1861413-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | McGILL UNIVERSITY (CA) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006096963-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY (CA) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055276-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | IGF2BP1, IGF2BP2, IGF2BP3 | TACR2 4393/4885CA12 1262/4885CA1 1263/4885 |
| US-20100041869-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | IGF2BP1, IGF2BP2, IGF2BP3 | TACR2 4393/4885CA12 1262/4885CA1 1263/4885 |
| US-10059736-B2 | Ionic liquid supported synthesis | IGF2BP1, IGF2BP2, IGF2BP3 | TACR2 4393/4885CA12 1262/4885CA1 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.